Search contract descriptions, companies and agencies.
HUMAN ALVEOLAR AND TRACHEOBRONCHIAL TISSUES FOR VIRAL INFECTION/DISEASE MODELING AND ANTIVIRAL
DISCOVERY FOR SARS-COV2
Total Committed
$202K
Product or Service Description
Drugs and Biologicals
Total Potential Value
$202K
Contracting Agency
Effective Date
Dec. 23, 2020
Funding Department
NATIONAL INSTITUTES OF HEALTH NCATS
Type
Firm fixed price
Solicitation Procedure
Simplified acquisition
Extent Competed
Not competed under sap
Reason
Sap Non Competition (Far 13)
Recent Contract Actions 
Contracts can have multiple “contract actions”: This is how agencies spend money for a specific purpose, adjust the amount committed or change the contract in a way that doesn’t affect the amount. That last scenario is usually indicated by a $0 action. If there is a contract action for a negative amount, it generally means the contract was adjusted or canceled.
| Vendor | Description | Signed | Reason for Change | Amount Committed |
|---|---|---|---|---|
| MATTEK CORPORATION | HUMAN ALVEOLAR AND TRACHEOBRONCHIAL TISSUES FOR VIRAL INFECTION/DISEASE MODELING AND ANTIVIRAL DISCOVERY FOR SARS-COV2. CONTRACT TERM 12/23/2020 - 8/31/2021. MODIFICATION P00001 MAKES A CORRECTION TO THE ORIGINAL AWARD. | Feb. 16, 2021 | Supplemental Agreement For Work Within Scope | -$26,758 |
| MATTEK CORPORATION | HUMAN ALVEOLAR AND TRACHEOBRONCHIAL TISSUES FOR VIRAL INFECTION/DISEASE MODELING AND ANTIVIRAL DISCOVERY FOR SARS-COV2 | Dec. 23, 2020 | $228,786 |
About this data
This data comes from the Federal Procurement Data System, which includes all contracts worth $10,000 or more. We look at all contracts that are tagged with the procurement code for COVID-19 or otherwise started in 2020 and contain “COVID-19” in the description. Department of Defense contracting data is subject to a 90-day delay before it appears in the data.